
In this conversation, I speak with Matthew Wall, PhD, about the effects of psilocybin and other classic psychedelics on the human brain.
Matthew Wall is a psychologist specializing in psychedelics and functional MRI (fMRI) neuroimaging. He earned his PhD in Cognitive and Brain Sciences from the University of Cambridge. Currently, he leads MRI Applications at Perceptive London and serves as an Honorary Senior Lecturer at Imperial College London.
Learn more about Matthew Wall's work: https://profiles.imperial.ac.uk/matthew.wall
Episode chapters:
00:00:00 Defining "Classic" Psychedelics: Psilocybin, LSD, DMT, and Mescaline
00:02:47 How Matthew Wall Got Involved in Psychedelic Research and His Motivations
00:09:00 Effectiveness of Psilocybin for Treatment-Resistant Depression
00:16:40 Insights from Larger Clinical Trials on Psilocybin's Effect on Depressive Symptoms
00:22:32 Comparing the Acute and Sustained Effects of Psychedelics vs. SSRIs for Depression
00:32:12 Understanding fMRI, Resting State Functional Connectivity (RSFC), and Arterial Spin Labeling
00:39:59 The Acute Effects of Classic Psychedelics on Global and Modular Brain Network Integration
00:47:57 Potential Risks, the Importance of Psychotherapy in Psychedelic Treatment, and Reopening Critical Learning Periods
01:07:48 Effects of Psychedelics on the Default Mode Network (DMN) and Other Key Brain Areas Like the Amygdala
01:33:36 Long-Term Effects of Psilocybin on Personality and The Future of Psychedelic Therapy